Asia Pacific Genomics Market

Historic Data: 2017-2018   |   Base Year: 2019   |    Forecast Period: 2020-2027

Analysis By Technology (Sequencing, Microarray, Polymerase chain reaction (PCR), Nucleic Acid Extraction and Purification, and Others), Product & Service (Instruments/Systems, Consumables, and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research, and Others), End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, and Others), and Country


No. of Pages: 225  |  Report Code: TIPRE00004303  |  Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Genomics Market

The Asia Pacific Genomics market is expected to reach US$ 11,574.11 million in 2027 from US$ 4,269.80 million in 2019. The market is estimated to grow with a CAGR of 13.6% from 2020-2027.

Genomics is  a branch of biotechnology concerned with applying the techniques of genetics and molecular biology to the genetic mapping and DNA sequencing of sets of genes or the complete genomes of selected organisms, with organizing the results in databases, and with applications of the data (as in medicine or biology). The major factors attributing to the growth of the genomics market are growing government support and increased number of genomics studies, declining sequencing cost, increased genomics applications. The scope of the genomics market includes technology, product and service, application, end-user, and region.

Japan Genomics Market Revenue and Forecasts to 2027 (US$ MN)

Japan Genomics Market Revenue and Forecasts to 2027 (US$ MN)

ASIA PACIFIC GENOMICS MARKET SEGMENTATION

By Technology

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

By Product and Services

  • Instruments/Systems
  • Consumables
  • Services

By Application

  • Diagnostics
  • Drug Discovery and Development
  • Precision/Personalized Medicine
  • Agriculture & Animal Research
  • Others

By End User

  • Research Centers
  • Hospitals & Clinics
  • Biotechnology & Pharmaceutical Companies
  • Others

By Country

  • Asia Pacific

    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific

Company Profiles

  • Illumina, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES INC.
  • General Electric Company
  • THERMO FISHER SCIENTIFIC INC.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • QIAGEN
  • BGI

Asia Pacific Genomics Strategic Insights

Strategic insights for the Asia Pacific Genomics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-genomics-market-strategic-framework.webp
Get more information on this report

Asia Pacific Genomics Report Scope

Report Attribute Details
Market size in 2019 US$ 4,269.80 Million
Market Size by 2027 US$ 11,574.11 Million
Global CAGR (2020 - 2027) 13.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Technology
  • Sequencing
  • Microarray
  • Polymerase chain reaction
  • Nucleic Acid Extraction and Purification
By Product & Service
  • Instruments/Systems
  • Consumables
  • Services
By Application
  • Diagnostics
  • Drug Discovery and Development
  • Precision/Personalized Medicine
  • Agriculture & Animal Research
By End User
  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical & Biotechnology Companies
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Illumina, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES INC.
  • General Electric Company
  • THERMO FISHER SCIENTIFIC INC.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • QIAGEN
  • BGI
Get more information on this report

Asia Pacific Genomics Regional Insights

The geographic scope of the Asia Pacific Genomics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

geography/asia-pacific-genomics-market-geography.webp
Get more information on this report

The List of Companies - Asia Pacific Genomics Market

  1. Illumina, Inc.
  2. Danaher
  3. F. HOFFMANN-LA ROCHE LTD.
  4. BIO-RAD LABORATORIES INC.
  5. General Electric Company
  6. THERMO FISHER SCIENTIFIC INC.
  7. Agilent Technologies, Inc.
  8. Eurofins Scientific
  9. QIAGEN
  10. BGI
Frequently Asked Questions
How big is the Asia Pacific Genomics Market?

The Asia Pacific Genomics Market is valued at US$ 4,269.80 Million in 2019, it is projected to reach US$ 11,574.11 Million by 2027.

What is the CAGR for Asia Pacific Genomics Market by (2020 - 2027)?

As per our report Asia Pacific Genomics Market, the market size is valued at US$ 4,269.80 Million in 2019, projecting it to reach US$ 11,574.11 Million by 2027. This translates to a CAGR of approximately 13.6% during the forecast period.

What segments are covered in this report?

The Asia Pacific Genomics Market report typically cover these key segments-

  • Technology (Sequencing, Microarray, Polymerase chain reaction, Nucleic Acid Extraction and Purification)
  • Product & Service (Instruments/Systems, Consumables, Services)
  • Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Genomics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Genomics Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Asia Pacific Genomics Market?

    The Asia Pacific Genomics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Illumina, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES INC.
  • General Electric Company
  • THERMO FISHER SCIENTIFIC INC.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • QIAGEN
  • BGI
  • Who should buy this report?

    The Asia Pacific Genomics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Genomics Market value chain can benefit from the information contained in a comprehensive market report.